News & Updates

Show Multimedia Only

Norwegian cheese variant may keep bone weakening at bay

10 Oct 2022 by

Consuming Jarlsberg cheese – a type of Norwegian cheese that contains long-chained vitamin K2 and DHNA* – may help fend off bone weakening, a study from Norway has shown. What’s more, it appears to do so without adversely affecting lipid levels, even extending its benefit to glycated haemoglobin levels.

10 Oct 2022

Pan-enteric capsule endoscopy accurately diagnoses IBD

10 Oct 2022 by

The use of pan-enteric capsule endoscopy (PCE) leads to high diagnostic yield for inflammatory bowel diseases (IBDs), often even matching that of colonoscopy and magnetic resonance enterography (MRE), reports a recent meta-analysis.

10 Oct 2022

Boys born to moms with GDM at risk of neurodevelopmental delays

10 Oct 2022

Neurodevelopment appears to be significantly delayed at up to 4 years of age in boys who are born to mothers with gestational diabetes mellitus (GDM), reports a recent study.

10 Oct 2022

SGLT2i does not worsen lower-limb amputation risk

10 Oct 2022

Among patients with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 inhibitors {SGLT2i) does not appear to increase the risk of lower-limb amputation, a recent study has found.

10 Oct 2022

Statin plus ezetimibe combo for lower LDL-C targets effective at reducing stroke risk

10 Oct 2022

Treatment with the combination of statin and ezetimibe to achieve a low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL works well to consistently reduce the risk of subsequent stroke, according to a post hoc analysis of the Treat Stroke to Target (TST) trial.

10 Oct 2022

Wearing of e-mask prevents droplet dispersal during bronchoscopy

09 Oct 2022

Use of the novel endoscopic mask (e-mask) during bronchoscopy results in a substantial decrease in the generation of airborne particles without increasing complications, according to a study.

09 Oct 2022

Does age at diagnosis affect diabetes outcomes?

09 Oct 2022 by

Individuals who are diagnosed with type 2 diabetes (T2D) at age ≤40 years have a greater risk of cardiovascular disease (CVD) and mortality than same-aged individuals without T2D or individuals diagnosed with T2D in later life, according to a study from Korea presented at EASD 2022.

09 Oct 2022

Plasma glutamate, amino acid profiles altered in type 1 diabetes

09 Oct 2022

Among patients with type 1 diabetes (T1D), alterations in plasma glutamate levels and free amino acid profiles are distinct than that in type 2 diabetes (T2D) patients and healthy controls, a recent study has found.

09 Oct 2022

Seropositive non-CTD ILD not linked to improved outcomes, treatment response

08 Oct 2022

Seropositivity in patients with interstitial lung disease (ILD) without connective tissue disease (CTD) does not seem to contribute to improved outcomes or treatment response, a study has shown.

08 Oct 2022

Bronchodilators ineffective in symptomatic, tobacco-exposed patients without COPD

08 Oct 2022 by

Bronchodilators, used in the treatment of chronic obstructive pulmonary disease (COPD), did not appear to benefit individuals with a history of smoking and respiratory symptoms who did not have airflow obstruction, results of the US-based RETHINC* study showed.

08 Oct 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Norwegian cheese variant may keep bone weakening at bay

Pan-enteric capsule endoscopy accurately diagnoses IBD

Boys born to moms with GDM at risk of neurodevelopmental delays

SGLT2i does not worsen lower-limb amputation risk

Statin plus ezetimibe combo for lower LDL-C targets effective at reducing stroke risk

Wearing of e-mask prevents droplet dispersal during bronchoscopy

Does age at diagnosis affect diabetes outcomes?

Plasma glutamate, amino acid profiles altered in type 1 diabetes

Seropositive non-CTD ILD not linked to improved outcomes, treatment response

Bronchodilators ineffective in symptomatic, tobacco-exposed patients without COPD